Optimer Financial Statements
Optimer Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | December |
This data is provided as per license from EDGAR Online
Optimer Income Statement
| 2007 | 2006 | 2005 | |
|---|---|---|---|
| Revenue ($ mil.) | 0.8 | 0.9 | 2.2 |
| Gross Profit ($ mil.) | -- | -- | -- |
| Operating Income ($ mil.) | (48.2) | (13.1) | (7.7) |
| Total Net Income ($ mil.) | (46.1) | (11.9) | (7.4) |
| Diluted EPS (Net Income) | (2.12) | (4.81) | (1.48) |
Optimer Stock Quote & Chart
09/05/08 15:00:06 EST •
NASDAQ •
8.11
•
 +0.1300
•
+1.6291 %
|
|---|
|
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
|
Optimer Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 258.19 | 3.69 | 1.54 |
| Price/Earnings Ratio | -- | 15.22 | 15.51 |
| Price/Book Ratio | 7.24 | 2.94 | 1.48 |
| Price/Cash Flow Ratio | -- | 12.49 | 9.68 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed Optimer Financial Ratios
Optimer Competitive Intelligence
| Bayer Corp. | Pfizer | Sanofi-Aventis | |
|---|---|---|---|
| Annual Sales ($ mil.) | 10,262.8 | 48,418.0 | 43,019.0 |
| Employees | 17,200 | 86,600 | 99,495 |
| Market Cap ($ mil.) | -- | 129,966.4 | -- |
Competitive Landscape
